*** Cet épisode est accessible uniquement aux membres premium ***
Pour les membres, voici les instructions pour écouter les épisodes premium.
Un nouvel épisode du pharmascope est maintenant disponible! Dans de ce 93ème épisode, Nicolas, Sébastien et Isabelle reçoivent un invité pour discuter de tout ce qu’il y a à savoir sur les effets indésirables sexuels liés aux antidépresseurs.
Les objectifs pour cet épisode sont les suivants:
- Décrire les effets indésirables sexuels potentiels associés aux antidépresseurs
- Expliquer les bénéfices et les inconvénients des diverses stratégies pouvant améliorer les plaintes sexuelles liées à la prise d’un antidépresseur
Ressources pertinentes en lien avec l’épisode
Serretti A, Chiesa A. Treatment-emergent sexual dysfunction related to antidepressants: a meta-analysis. J Clin Psychopharmacol. 2009 Jun;29(3):259-66.
Reichenpfeider U, Gartlehner G, Morgan LC, et coll. Sexual dysfunction associated with second-generation antidepressants in patients with major depressive disorder: results from a systematic review with network meta-analysis. Drug Saf. 2014 Jan;37(1):19-31.
Watanabe R, Omori IM, Nakagawa A, et coll. Mirtazapine versus other antidepressive agents for depression. Cochrane Database Syst Rev. 2011 Dec 7;(12):CD006528.
Thase ME, Haight BR, Richard N et coll. Remission rates following antidepressant therapy with bupropion or selective serotonin reuptake inhibitors: a meta-analysis of original data from 7 randomized controlled trials. J Clin Psychiatry. 2005; 66(8): 974-81.
Delgado PL, Brannan SK, Mallinckrodt CH et coll. Sexual functioning assessed in 4 double-blind placebo- and paroxetine-controlled trials of duloxetine for major depressive disorder. J Clin Psychiatry. 2005; 66(6): 686-92.
Clayton A, Kornstein S, Prakash A et coll. Changes in sexual functioning associated with duloxetine, escitalopram, and placebo in the treatment of patients with major depressive disorder. J Sex Med. 2007; 4(4 Pt 1): 917-29.
Montejo-González AL, Llorca G, Izquierdo JA et coll. SSRI-induced sexual dysfunction: fluoxetine, paroxetine, sertraline, and fluvoxamine in a prospective, multicenter, and descriptive clinical study of 344 patients. J Sex Marital Ther. 1997; 23(3): 176-94.
Jacobsen PL, Mahableshwarkar AR, Chen Y et coll. Effect of Vortioxetine vs. Escitalopram on Sexual Functioning in Adults with Well-Treated Major Depressive Disorder Experiencing SSRI-Induced Sexual Dysfunction. J Sex Med. 2015; 12(10): 2036-48.
Taylor MJ, Rudkin L, Bullemor-Day P et coll. Strategies for managing sexual dysfunction induced by antidepressant medication.Cochrane Database Syst Rev. 2013; (5): CD003382.
Clayton AH, Warnock JK, Kornstein SG et coll. A placebo-controlled trial of bupropion SR as an antidote for selective serotonin reuptake inhibitor-induced sexual dysfunction. J Clin Psychiatry. 2004 Jan;65(1):62-7.
Aizenberg D, Zemishlany Z, Weizman A. Clin Neuropharmacol. Cyproheptadine treatment of sexual dysfunction induced by serotonin reuptake inhibitors. 1995; 18(4): 320-4.
Fava M, Dording CM, Baker RA, et coll. Effects of Adjunctive Aripiprazole on Sexual Functioning in Patients With Major Depressive Disorder and an Inadequate Response to Standard Antidepressant Monotherapy: A Post Hoc Analysis of 3 Randomized, Double-Blind, Placebo-Controlled Studies. Prim Care Companion CNS Disord. 2011; 13(1): PCC.10m00994.
Ravindran AV, Kennedy SH, O’Donovan MC, et coll. Osmotic-release oral system methylphenidate augmentation of antidepressant monotherapy in major depressive disorder: results of a double-blind, randomized, placebo-controlled trial. J Clin Psychiatry. 2008 Jan;69(1):87-94.
Fooladi E, Bell RJ, Jane F, et coll. Testosterone improves antidepressant-emergent loss of libido in women: findings from a randomized, double-blind, placebo-controlled trial. J Sex Med. 2014 Mar;11(3):831-9.
Lorenz TA, Meston CM. Exercise improves sexual function in women taking antidepressants: results from a randomized crossover trial. Depress Anxiety. 2014 Mar;31(3):188-95.
